STOCK TITAN

Sagimet Biosciences: Balyasny reports about 9% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

An amended Schedule 13G concerning Sagimet Biosciences Inc. (SGMT) reports that five reporting persons may each be deemed to beneficially own 5,542,492 Series A common shares, approximately 9.00% of the class. The shares are held directly by Atlas Diversified Master Fund, Ltd. (3,042,492 shares) and Atlas Private Holdings (Cayman) Ltd. (2,500,000 shares). Balyasny Asset Management L.P., BAM GP LLC, Balyasny Asset Management Holdings LP, Dames GP LLC and Dmitry Balyasny report sole voting and dispositive power over the shares through the stated management and control relationships. The percentage is based on 61,591,159 shares outstanding as of August 4, 2026.

Beneficial ownership reported 5,542,492 shares Each of the five reporting persons may be deemed to beneficially own this reported position.
Ownership percentage approximately 9.00% Each reporting person's reported share of the Series A common stock class.
Shares held by Atlas Diversified Master Fund, Ltd. 3,042,492 shares Direct holder of the reported shares.
Shares held by Atlas Private Holdings (Cayman) Ltd. 2,500,000 shares Direct holder of the reported shares.
Shares outstanding 61,591,159 shares As of August 4, 2026; basis for the reported ownership percentage.
beneficially own regulatory
"may be deemed to beneficially own such Shares"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
Sole Voting Power regulatory
"Sole Voting Power: 5,542,492.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
Sole Dispositive Power regulatory
"Sole Dispositive Power: 5,542,492.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who receives dividends or sale proceeds from SGMT shares in the amended ownership report?

Atlas Diversified Master Fund, Ltd. and Atlas Private Holdings (Cayman) Ltd., both investment-management clients of Balyasny Asset Management L.P., have the right to receive dividends from or proceeds from sales of the reported shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





786700104

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



BALYASNY ASSET MANAGEMENT L.P.
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
BAM GP LLC
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Balyasny Asset Management Holdings LP
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Dames GP LLC
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Dmitry Balyasny
Signature:/s/ Dmitry Balyasny
Name/Title:Dmitry Balyasny / Self
Date:11/16/2026

Keep reading